Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
TXMDCompany Name
THERAPEUTICSMD INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQTHERAPEUTICSMD INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TXMD - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ -243K | $ 12.79M | 0 |
| 3/31/2025 | $ 479K | $ 17.59M | 36.73 |
| 12/31/2024 | $ 732K | $ 12.15M | 16.6 |
| 9/30/2024 | $ -7.12M | $ 17.3M | 0 |
| 6/30/2024 | $ -9.39M | $ 19.26M | 0 |
| 3/31/2024 | $ -14.73M | $ 23.41M | 0 |
| 12/31/2023 | $ -48.14M | $ 26.41M | 0 |
| 9/30/2023 | $ 19.49M | $ 21.26M | 1.09 |
| 6/30/2023 | $ 3.03M | $ 40.71M | 13.45 |
| 3/31/2023 | $ -7.68M | $ 45.05M | 0 |
Key Performance Insights, Last 5 Years
- THERAPEUTICSMD INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, THERAPEUTICSMD INC's average P/FCF has been 16.97.
- The median P/FCF for THERAPEUTICSMD INC during this period was 15.03
- THERAPEUTICSMD INC reached its highest P/FCF over the past 5 years at 36.73.
- The lowest P/FCF recorded by THERAPEUTICSMD INC in the same timeframe 1.09
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for THERAPEUTICSMD INC is calculated as follows: Market Cap [ $ 414.67M ] / FCF [ $ -180.35M ]
(=) P/FCF [ 0 ] TXMD - Price to Free Cash Flow, Last 5 years
1.09
Minimum
Sep 30, 2023
36.73
Maximum
Mar 31, 2025
16.97
Average
15.03
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.31 with a standard deviation of 12.93.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.31 |
| median | 14.73 |
| std | 12.93 |